Advanced Precision Cancer Medicine Forum to be Held on 8/27


Precision medicine is a global development trend, and Taiwan is expected to include NGS (Next-Generation Sequencing) in its health insurance by 2024, enabling more precise cancer treatment and potentially reducing the economic burden on cancer patients. Organized by the Taiwan Oncology Society and co-hosted by entities like ACT Genomics, the Advanced Precision Cancer Medicine Forum (APCM) will be held on August 27th, focusing on the future planning, strategic implementation, and clinical applications of precision cancer medicine in Taiwan.